Post-transplantation Diabetes Mellitus
Conditions
Brief summary
The occurrence of PTDM in the first six months after receiving a kidney transplantation
Detailed description
Laboratory markers: eGFR, urine protein-creatinine ratio, HbA1c and lipid profile, Anthropometric markers: body weight and blood pressure, Occurrence of rejection up to 6 months after kidney transplantation, Questionnaires will be used to assess experienced health (SF-36 for general quality of life and GSRS for gastrointestinal symptoms), β-cell function will be assessed using a hyperglycaemic clamp with glucagon stimulation (RUMC only).
Interventions
DRUGGlucose 20 %
DRUGGlucaGen Hypokit 1 mg poeder en oplosmiddel voor oplossing voor injectie.
Sponsors
Radboud universitair medisch centrum Stichting
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The occurrence of PTDM in the first six months after receiving a kidney transplantation | — |
Secondary
| Measure | Time frame |
|---|---|
| Laboratory markers: eGFR, urine protein-creatinine ratio, HbA1c and lipid profile, Anthropometric markers: body weight and blood pressure, Occurrence of rejection up to 6 months after kidney transplantation, Questionnaires will be used to assess experienced health (SF-36 for general quality of life and GSRS for gastrointestinal symptoms), β-cell function will be assessed using a hyperglycaemic clamp with glucagon stimulation (RUMC only). | — |
Outcome results
None listed